Swiss Biotech Roivant Sciences Enters Wall Street with a $611 Million SPAC Merger
The number of special purpose acquisition company (SPAC) acquisitions is rising in the biotech industry due to its transformative way of changing how a company goes public. SPAC, also known …
Read More